Hybrid Peptides: A Novel Domain in Drug Identification
Chimera peptides, designed by fusing segments from multiple peptide sequences, represent a promising strategy for solving limitations in traditional drug design. This burgeoning field permits researchers to create molecules with superior properties, such as improved binding for specific proteins